The head of the drug manufacturer AstraZeneca is developing a coronavirus vaccine, which is expected to be approved by British authorities this week. Infected in the UK.
Pascal Soriot, CEO of AstraZeneca, also told the Sunday Times that the researchers who developed the vaccine had found a “successful formula.” Make the jab as effective as a competitor candidate.
Some people worry that the AstraZeneca vaccine developed by the University of Oxford may not be as good as the vaccine produced by Pfizer, which has already been distributed in the UK and other countries. Some results show that compared with the 95% efficacy reported by Pfizer and its German partner BioNTech, AstraZeneca injection can effectively prevent diseases caused by coronavirus infection.
Soriot said: “We think we have figured out how to win and how to get an effective dose. After two doses, everyone else can use it.”
The British government said its drug regulatory agency is reviewing the final data of AstraZeneca’s Phase III clinical trial. The Times and other reports stated that the green light may arrive on Thursday and that the vaccine could be introduced to the British public in the first week of January.
When asked about the efficacy of the vaccine against the new coronavirus variants circulating in the UK, Soriot said: “So far, we think the vaccine should remain effective. But we are not sure, so we will test it. .”
British authorities accused the new virus variants of soaring infection rates across the country. They say that the variant is easier to spread, but it should be emphasized that there is no evidence that the variant will make people sick.
Prime Minister Boris Johnson sounded the emergency alert for variants a few days before Christmas. He said that a new version of the virus is spreading rapidly and plans to travel and gather millions of people must be cancelled. Since then, the authorities have imposed the strictest restrictions on more and more areas of the country, which affected approximately 24 million people, accounting for 43% of the population.
Many countries quickly banned travel from the UK, but since then cases of this new model have been reported in more than a dozen places around the world.
Public health officials said on December 24 that more than 600,000 people had received two doses of Pfizer vaccine.